adenocarcinoma of unknown primary

Known as: adenocarcinoma, unknown primary, unknown primary, adenocarcinoma, adenocarcinoma primary unknown 
An adenocarcinoma which has metastasized from an unknown primary anatomic site.
National Institutes of Health

Topic mentions per year

Topic mentions per year

1964-2017
051019642017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
BACKGROUND Cisplatin-based combination chemotherapy is commonly used in the treatment of carcinoma of unknown primary site… (More)
Is this relevant?
2002
2002
BACKGROUND Metastatic cancer of unknown primary site occupies 0.5-10% of all diagnosed cancer patients and includes various… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
2000
2000
PURPOSE To determine the frequency of Her-2 overexpression in patients with poorly differentiated carcinoma or poorly… (More)
Is this relevant?
1998
1998
Cutaneous manifestations of malignancy are not uncommon, especially in advanced disease. They may also occur early in malignant… (More)
Is this relevant?
1992
1992
PURPOSE We previously reported excellent responses to cisplatin-based chemotherapy in a minority of patients with poorly… (More)
Is this relevant?
1989
1989
STUDY OBJECTIVE To define the clinical features and results of systemic treatment in women with adenocarcinoma of unknown primary… (More)
Is this relevant?
1989
1989
Nineteen patients with adenocarcinoma of unknown primary were treated with the m-FAM regimen, consisting of methotrexate 50 mg/m2… (More)
Is this relevant?
1987
1987
Of 101 patients with symptomatic adenocarcinoma or undifferentiated carcinoma of unknown primary site, 95 were evaluable for the… (More)
Is this relevant?
1983
1983
Twenty-five adult patients with adenocarcinoma of unknown primary origin were treated with oral tegafur followed by the… (More)
Is this relevant?
1979
1979
An analysis of the clinico-pathological findings in 49 patients with adenocarcinoma of unknown primary origin indicates a short… (More)
Is this relevant?